JP2021514387A5 - - Google Patents

Info

Publication number
JP2021514387A5
JP2021514387A5 JP2020565545A JP2020565545A JP2021514387A5 JP 2021514387 A5 JP2021514387 A5 JP 2021514387A5 JP 2020565545 A JP2020565545 A JP 2020565545A JP 2020565545 A JP2020565545 A JP 2020565545A JP 2021514387 A5 JP2021514387 A5 JP 2021514387A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
immunogenic composition
composition according
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020565545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021514387A (ja
Filing date
Publication date
Priority claimed from GBGB1802339.0A external-priority patent/GB201802339D0/en
Application filed filed Critical
Publication of JP2021514387A publication Critical patent/JP2021514387A/ja
Publication of JP2021514387A5 publication Critical patent/JP2021514387A5/ja
Pending legal-status Critical Current

Links

JP2020565545A 2018-02-13 2019-02-12 ブドウ球菌抗原を含む免疫原性組成物 Pending JP2021514387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1802339.0 2018-02-13
GBGB1802339.0A GB201802339D0 (en) 2018-02-13 2018-02-13 Immunogenic composition
PCT/EP2019/053463 WO2019158537A1 (en) 2018-02-13 2019-02-12 Immunogenic composition comprising staphylococcal antigens

Publications (2)

Publication Number Publication Date
JP2021514387A JP2021514387A (ja) 2021-06-10
JP2021514387A5 true JP2021514387A5 (cg-RX-API-DMAC7.html) 2022-02-17

Family

ID=61731342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565545A Pending JP2021514387A (ja) 2018-02-13 2019-02-12 ブドウ球菌抗原を含む免疫原性組成物

Country Status (15)

Country Link
US (2) US11426455B2 (cg-RX-API-DMAC7.html)
EP (1) EP3752183A1 (cg-RX-API-DMAC7.html)
JP (1) JP2021514387A (cg-RX-API-DMAC7.html)
KR (1) KR20200121825A (cg-RX-API-DMAC7.html)
CN (1) CN112153980A (cg-RX-API-DMAC7.html)
AR (1) AR114627A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019221496B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020016373A2 (cg-RX-API-DMAC7.html)
CA (1) CA3090609A1 (cg-RX-API-DMAC7.html)
EA (1) EA202091690A1 (cg-RX-API-DMAC7.html)
GB (1) GB201802339D0 (cg-RX-API-DMAC7.html)
IL (1) IL276661B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020008454A (cg-RX-API-DMAC7.html)
SG (1) SG11202007676RA (cg-RX-API-DMAC7.html)
WO (1) WO2019158537A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721582D0 (en) * 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
CN110511950B (zh) * 2019-07-29 2022-03-08 因之彩生物科技(武汉)有限公司 Pab蛋白在构建具有类伴侣样蛋白作用的融合蛋白表达载体中的应用
EP3777884A1 (en) * 2019-08-15 2021-02-17 GlaxoSmithKline Biologicals S.A. Immunogenic composition
US20230045642A1 (en) 2019-12-19 2023-02-09 Glaxosmithkline Biologicals Sa S. aureus antigens and compositions thereof
AU2021262999A1 (en) 2020-05-01 2023-01-19 Sinocelltech Ltd. Method for improving immunogenicity of protein/peptide antigen
KR20220039610A (ko) 2020-09-21 2022-03-29 주식회사 엘지에너지솔루션 리튬 이차전지 활성화 방법 및 리튬 이차전지
CN121081612A (zh) * 2024-05-30 2025-12-09 江苏坤力生物制药有限责任公司 一种金黄色葡萄球菌纳米化抗原、含其的疫苗及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2730275T3 (es) * 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
GB0526038D0 (en) 2005-12-21 2006-02-01 Glaxosmithkline Biolog Sa Immunogenic composition
CA2713241C (en) * 2008-01-31 2022-10-04 Timothy Foster Treatment of microbial infections
AU2015202532A1 (en) 2009-04-14 2015-06-04 Novartis Ag Compositions for immunising against Staphylococcus aureus
AU2010264538B2 (en) * 2009-06-22 2013-10-03 Wyeth Llc Immunogenic compositions of Staphylococcus aureus antigens
US20140037650A1 (en) 2009-07-24 2014-02-06 University Of Chicago Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
WO2011138361A1 (en) * 2010-05-06 2011-11-10 Glycovaxyn Capsular gram-positive bacteria bioconjugate vaccines
AU2011274367B2 (en) * 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago 感染防御ブドウ球菌抗原が関与する方法および組成物
HUE033072T2 (hu) 2010-12-22 2017-11-28 Wyeth Llc Staphylococcus aureus antigének immunogén készítményei
US9556281B2 (en) * 2011-08-15 2017-01-31 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein A
EP2890387A1 (en) * 2012-08-31 2015-07-08 Novartis AG Stabilised proteins for immunising against staphylococcus aureus
CN106163550A (zh) 2013-12-04 2016-11-23 格林考瓦因有限公司 通过大肠杆菌中合成的糖蛋白疫苗预防金黄色葡萄球菌感染
MX377794B (es) * 2014-03-26 2025-03-10 Glaxosmithkline Biologicals Sa Antigenos estafilococicos mutantes.
GB201721582D0 (en) * 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
GB201721576D0 (en) * 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof

Similar Documents

Publication Publication Date Title
IL276661B2 (en) Immunogenic preparation containing staphylococcal antigens
JP2016502551A5 (cg-RX-API-DMAC7.html)
RU2375374C2 (ru) Домены и эпитопы менингококкового белка nmb1870
HRP20190711T1 (hr) Imunogeni pripravak
JP4509554B2 (ja) アルミニウムアジュバントおよびヒスチジンを含むワクチン
EP2026841B1 (en) Conjugation process for pnag and a carrier protein
RU2007145052A (ru) Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера
US9775898B2 (en) Vaccine composition comprising an immunogenic protein and combination adjuvants for use in eliciting antigen-specific T-cell responses
AU719084B2 (en) Iscom or iscom-matrix comprising a mucus targetting substance and optionally, an antigen
HU229968B1 (hu) Sztreptokokkusz oltóanyag
CA2190344C (en) Quillaja saponin adjuvant and vaccine formulation containing same
JP2004538330A (ja) 免疫応答増強剤
CN1238696A (zh) 疫苗
CN104093418A (zh) 金黄色葡萄球菌抗原的含佐剂制剂
US10159729B2 (en) Antigen and method for production thereof
RU2011153032A (ru) Вакцины и композиции, направленные против streptococcus pneumoniae
RU2014127714A (ru) ВАКЦИНА НА ОСНОВЕ ТОКСИНОВ Clostridium difficile
RU2017129340A (ru) Композиции nеisseria мeningitidis и способы их получения
US12115215B2 (en) Composition and method for generating immunity to borrelia burgdorferi
JP2017511327A5 (cg-RX-API-DMAC7.html)
ES2701084T3 (es) Compuestos inmunogénicos que comprenden péptido gp41 de VIH acoplado a proteína portadora CRM197
RU2015106742A (ru) Композиции, содержащие химерные молекулы ospa и способы их применения
JP5661744B2 (ja) 腸球菌由来のポリペプチド、及びワクチン接種のためのその使用
JP2009514840A5 (cg-RX-API-DMAC7.html)
KR910000179A (ko) Aids용 결합체 면역원